Drug intelligence / Profile preview

3,8-diamino-6-phenyl-5-[6-[1-[2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl]-1h-1,2,3-triazol-5-yl]hexyl]-phenanthridinium

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the molecular formula C42H45N8+ and a molecular weight of approximately 661.9 g/mol[1][5]. It features a phenanthridinium core substituted with diamino and phenyl groups as well as an extended side chain containing both triazole and tetrahydroacridine moieties. The structure suggests potential DNA intercalating properties due to its planar aromatic system and cationic nature—features common among DNA-binding dyes or agents[7]. However, there is no evidence that this compound has been approved for clinical use or advanced beyond experimental investigation. Its mechanism of action is not explicitly described in available sources but may involve nucleic acid binding/intercalation.

Other names
3,8-Diamino-6-Phenyl-5-(6-(1-(2-((1,2,3,4-Tetrahydroacridin-9-Yl)Amino)Ethyl)-1H-1,2,3-Triazol-5-Yl)Hexyl)-Phenanthridinium3,8-diamino-6-phenylphenanthridiniumDB03005DB-03005DB 03005
02

Targets

DNA

Beyond the preview

Go deeper on 3,8-diamino-6-phenyl-5-[6-[1-[2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl]-1h-1,2,3-triazol-5-yl]hexyl]-phenanthridinium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3,8-diamino-6-phenyl-5-[6-[1-[2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl]-1h-1,2,3-triazol-5-yl]hexyl]-phenanthridinium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call